Advertisement Berkshire Hathaway acquires Lubrizol - Pharmaceutical Business review
Pharmaceutical Business review is using cookies

ContinueLearn More
Close

Berkshire Hathaway acquires Lubrizol

Berkshire Hathaway has acquired Lubrizol, a specialty chemical company that produces and supplies technologies to customers in the global transportation, industrial and consumer markets, for $135 per share.

Lubrizol is a producer of ingredients and additives for personal care products and pharmaceuticals; specialty materials, as well as plastics technology and performance coatings in the form of specialty resins and additives.

With this acquisition, Lubrizol has now become a wholly-owned subsidiary of Berkshire Hathaway.

Lubrizol chairman, president and CEO James Hambrick said as part of Berkshire Hathaway, they have significant opportunities to continue creating customer value by providing chemistries, formulations and solutions for some of the most demanding performance applications in the world.